Company profile

InteRNA Genomics B.V., a subsidiary of InteRNA Technologies, is co-founded by Dr. Eugene Berezikov and Dr. Edwin Cuppen, leading scientists in U-HTP data generation and analysis. Berezikov and Cuppen pioneered the application of high-throughput sequencing technologies for expression profiling and discovery of small RNAs and microRNAs in particular, as described in several high-profile publications.

InteRNA Genomics offers services and software for processing, analyzing and presenting ultra-high-throughput sequencing data generated by various platforms. InteRNA's proprietary informatics solutions, Intess™, convert large sets of raw sequencing data into interpretable formats and integrate this information with existing proprietary and public data resources.

Management team

Roel Schaapveld, COO

Roel joined InteRNA Genomics in February 2008 as COO to manage the company's day-to-day operations and to develop the company's strategy and opportunities for further development. Prior to InteRNA he was senior manager in the corporate finance biotech team at Dutch merchant bank Kempen & Co. Roel brings along more than 8 years experience in product and business development. He held several positions at KREATECH Biotechnology, among which VP Corporate and Business Development. Roel holds a M.Sc. in Molecular Biology and received his Ph.D. from the University of Nijmegen (the Netherlands). During his academic career he worked at the Roche Institute for Molecular Biology (Nutley, NJ), the Dana-Farber Cancer Institute (Boston, MA) and at the Netherlands Cancer Institute in Amsterdam. Roel received his MBA from Nyenrode Business School, The Netherlands.

Eugene Berezikov, co-founder

After obtaining his Ph.D. degree at the Institute of Cytology and Genetics in Novosibirsk (Russia) in 2000, Eugene Berezikov continued his scientific career as post-doc at the Netherlands Cancer Institute in Amsterdam (the Netherlands) and the Hubrecht Institute in Utrecht (the Netherlands). Here, he worked on homologous gene targeting in C.elegans and on the discovery of small RNAs. In 2007 he was appointed group leader of the small RNA biology research group at the Hubrecht Institute. As Head of Bioinformatics at InteRNA Genomics, he is responsible for all of the company's bioinformatics activities, including data analysis and the development of novel software and other computational tools.

Edwin Cuppen, co-founder

Dr. Edwin Cuppen is professor of Genome Biology at Utrecht University and staff scientist at the Hubrecht Institute (Utrecht, the Netherlands), where he heads a the group of 15 researchers that focuses on functional genomics in vertebrate model organisms. Edwin's research combines both experimental and bioinformatics approaches. His group was one of the first worldwide to generate knockouts in the rat. He obtained his Ph.D. in cell biology in 1998 at the University of Nijmegen (the Netherlands), and after a post-doc position at the Netherlands Cancer Institute in Amsterdam he joined the Hubrecht Institute in 2001 where he was appointed group leader in 2005.

Carreer Opportunities

InteRNA Genomics is hiring Bioinformaticians. Please contact us for more information.

Investors

Aglaia Oncology fund

managed by Aglaia Biomedical Ventures